STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2374 by analyst upside · 2026-06-27
PFE
Pfizer Inc.
Healthcare · Market Cap $138B · P/E 18.5x
ANALYST PRICE TARGET
+20.0%
implied upside to consensus target
Current Price $24.29
Consensus Target $29.15
Bull Target $36.0
Bear Target $24.0
Analysts Covering 27
ANALYST CONSENSUS — HOLD
Strong Buy
2
Buy
8
Hold
14
Sell
3
52-Week Low $23.11
52-Week High $28.75
YTD Return -0.3%
FUNDAMENTALS
Market Cap $138B
P/E Ratio (TTM) 18.5x
Forward P/E 8.6x
EPS (TTM) $1.31
PEG Ratio 13.77
Dividend Yield 7.08%
Revenue (TTM) $63.3B
Profit Margin 11.8%
52-WEEK RANGE
52-Week Low $23.11
52-Week High $28.75
Current Price $24.29
Bear Target $24.0
Bull Target $36.0
● Now $24.29 ● Target $29.15
TRADING DATA
Avg Volume 38.5M
YTD Return -0.3%
Analyst Count 27
Consensus Hold
Upside to Target +20.0%
Last Updated 2026-06-27

ANALYST SUMMARY

Pfizer Inc. (PFE) is currently trading at $24.29 with a Wall Street consensus price target of $29.15, implying potential upside of 20.0% over the next 12 months. 27 analysts currently cover PFE, with a consensus rating of Hold — 37% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $36.0, while the most cautious has a target of $24.0.

PFE operates in the Healthcare sector with a market capitalisation of $138B. The stock is down 0.3% year-to-date and is currently trading near the lower end of its 52-week range of $23.11 – $28.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PFE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital ↑ Upgrade
Underperform → Sector Perform 2026-06-10 Building track record
Citigroup — Reiterated
Neutral → Neutral 2026-04-29 Building track record
RBC Capital reit
Underperform → Underperform 2026-04-20 Building track record
CICC ● Initiated
Outperform 2026-04-16 Building track record
UBS — Reiterated
Neutral → Neutral 2026-04-13 33% win rate (6 calls)
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-04-10 Building track record
B of A Securities — Reiterated
Neutral → Neutral 2026-04-09 Building track record
Guggenheim — Reiterated
Buy → Buy 2026-03-24 62% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →